Clinical Trial Update: Security and Efficacy of Dorilax® (Fixed Association of Paracetamol 350 mg, Carisoprodol 150 mg and Caffeine 50 mg) Plus Thermal Band Compared to Placebo Plus Thermal Band in the Treatment of Acute Low Back Pain. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Dorilax (paracetamol/carisoprodol/caffeine) plus a thermal band for acute low back pain has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Dorilax (paracetamol/carisoprodol/caffeine)

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Low Back Pain | Phase 3 | Status: WITHDRAWN